Recognition of Genes Upregulated in ALK-Positive and Lung that is EGFR/KRAS/ALK-Negative Adenocarcinomas

Recognition of Genes Upregulated in ALK-Positive and Lung that is EGFR/KRAS/ALK-Negative Adenocarcinomas Abstract Activation of the EGFR, KRAS, and ALK oncogenes defines 3 various paths of molecular pathogenesis in lung adenocarcinoma. Nonetheless, many tumors lack activation of any path (triple-negative lung adenocarcinomas) posing a challenge for prognosis and therapy.